CLDX
Crestline filing amended LLC agreement
Crestline Lending Solutions filed its Third Amended and Restated Limited Liability Company Agreement, outlining the governance and investment terms for the company.
CLDX news
Latest 4 stories · newest Nov 4, 2026
CLDX
Celldex announces positive Phase 3 results for barzolvolimab in CSU
Celldex's barzolvolimab met primary and all secondary endpoints in Phase 3 trials for chronic spontaneous urticaria, leading to a potential FDA BLA submission in 2027.
CLDX
Celldex reports Q2 results; barzolvolimab Phase 3 data expected 2026
Celldex reported Q2 financial results, with Phase 3 enrollment for barzolvolimab in chronic spontaneous urticaria completed six months ahead of schedule.
CLDX
Celldex amends 2021 Equity Plan
Celldex Therapeutics filed an amendment to its 2021 Omnibus Equity Incentive Plan, expanding available stock by 3.4 million shares. This adjustment impacts future employee retention and compensation structures.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same CLDX feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/CLDX/newsSTART FREE